dc.contributor.author | Khan, Mohammed I | |
dc.contributor.author | Holek, Matthew | |
dc.contributor.author | Bdair, Faris | |
dc.contributor.author | Mbuagbaw, Lawrence | |
dc.contributor.author | Eldridge, Sandra M. | |
dc.contributor.author | Chan, Claire L. | |
dc.contributor.author | Campbell, Michael J. | |
dc.contributor.author | Bond, Christine M. | |
dc.contributor.author | Hopewell, Sally | |
dc.contributor.author | Lancaster, Gillian A. | |
dc.contributor.author | Thabane, Lehana | |
dc.date.accessioned | 2020-06-24T09:55:01Z | |
dc.date.available | 2020-06-24T09:55:01Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Khan , M I , Holek , M , Bdair , F , Mbuagbaw , L , Eldridge , S M , Chan , C L , Campbell , M J , Bond , C M , Hopewell , S , Lancaster , G A & Thabane , L 2020 , ' Assessing the transparency of informed consent in feasibility and pilot studies : a single-centre quality assurance study protocol ' , BMJ Open , vol. 10 , no. 6 , e036226 , pp. e036226 . https://doi.org/10.1136/bmjopen-2019-036226 | en |
dc.identifier.issn | 2044-6055 | |
dc.identifier.other | PURE: 171249665 | |
dc.identifier.other | PURE UUID: 0ffb3431-d528-4416-9453-235798ad8d4c | |
dc.identifier.other | Scopus: 85086913514 | |
dc.identifier.other | PubMed: 32571863 | |
dc.identifier.uri | https://hdl.handle.net/2164/14567 | |
dc.description | Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. | en |
dc.format.extent | 5 | |
dc.language.iso | eng | |
dc.relation.ispartof | BMJ Open | en |
dc.rights | © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. | en |
dc.subject | ethics (see medical ethics) | en |
dc.subject | medical ethics | en |
dc.subject | protocols & guidelines | en |
dc.subject | statistics & research methods | en |
dc.subject | R Medicine (General) | en |
dc.subject | Medicine(all) | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R1 | en |
dc.title | Assessing the transparency of informed consent in feasibility and pilot studies : a single-centre quality assurance study protocol | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1136/bmjopen-2019-036226 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85086913514&partnerID=8YFLogxK | en |
dc.identifier.vol | 10 | en |
dc.identifier.iss | 6 | en |